The benchmark indices remained in negative terrain with moderate losses amid volatility on October 23, continuing the downtrend for the third consecutive session, despite a positive market breadth. About 1,461 shares gained against 1,039 shares that fell on the NSE. The market is expected to sustain its downtrend amid consolidation, with a "sell on rally" strategy. Below are some trading ideas for...

The benchmark indices recorded a notable recovery from the day's low for another session, closing flat with a negative bias on July 11, while the breadth was positive. About 1,403 shares advanced, while 924 shares declined on the NSE. The Nifty 50 continued to defend 24,300, and if it breaks this level, then 24,200-24,100 is the next likely support area, while the resistance is placed at the 24,40...

Booster shotAn interesting tug of war playing out in Dr Reddy’s following the fourth quarter numbers. Massive volumes were seen in the ADRs on Friday, and on Monday too ADR volumes were higher than usual. Dr Reddy’s has been among the laggards in the pharma pack, and the near-term outlook remains cautious given continued price erosion in the US generic space and increased R&D spending. Price a...

Volte faceSome informed bulls appear to have jumped ship in Voltas just ahead of its disappointing fourth-quarter numbers announced post-market hours on Tuesday. The stock had been riding high after a strong fourth-quarter business update. However, its quarterly numbers showed that Voltas’s efforts at increasing market share are coming at the expense of margins. Mutual funds and PMS funds had lo...

Shares of Voltas Limited jumped 5 percent to Rs 1,365 in early trade on April 22 after UBS upgraded the stock recommendation to 'buy' from 'neutral' on robust growth prospects.The international brokerage more than doubled the price target from Rs 885 to Rs 1,800, indicating a massive upside potential of over 38 percent of Rs 1,300. Analysts suggest that the company will 'surprise' on market share ...